BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11933212)

  • 1. Globin gene transfer for the treatment of severe hemoglobinopathies: a paradigm for stem cell-based gene therapy.
    Sadelain M
    J Gene Med; 2002; 4(2):113-21. PubMed ID: 11933212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
    Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
    Persons DA
    Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Therapy Approaches to Hemoglobinopathies.
    Ferrari G; Cavazzana M; Mavilio F
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):835-852. PubMed ID: 28895851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Therapy for beta-thalassemia.
    Malik P; Arumugam PI
    Hematology Am Soc Hematol Educ Program; 2005; ():45-50. PubMed ID: 16304358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for hemoglobinopathies: the state of the field and the future.
    Chandrakasan S; Malik P
    Hematol Oncol Clin North Am; 2014 Apr; 28(2):199-216. PubMed ID: 24589262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taking the good out of the bad: lentiviral-based gene therapy of the hemoglobinopathies.
    Stathopulos PB
    Biotechnol Adv; 2003 Sep; 21(6):513-26. PubMed ID: 14499152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies.
    Bhukhai K; de Dreuzy E; Giorgi M; Colomb C; Negre O; Denaro M; Gillet-Legrand B; Cheuzeville J; Paulard A; Trebeden-Negre H; Borwornpinyo S; Sii-Felice K; Maouche L; Down JD; Leboulch P; Payen E
    Mol Ther; 2018 Feb; 26(2):480-495. PubMed ID: 29221807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Therapy for Hemoglobinopathies.
    Cavazzana M; Mavilio F
    Hum Gene Ther; 2018 Oct; 29(10):1106-1113. PubMed ID: 30200783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in stem cell transplantation and gene therapy in the β-hemoglobinopathies.
    Payen E; Leboulch P
    Hematology Am Soc Hematol Educ Program; 2012; 2012():276-83. PubMed ID: 23233592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.
    Negre O; Eggimann AV; Beuzard Y; Ribeil JA; Bourget P; Borwornpinyo S; Hongeng S; Hacein-Bey S; Cavazzana M; Leboulch P; Payen E
    Hum Gene Ther; 2016 Feb; 27(2):148-65. PubMed ID: 26886832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral Transfer of γ-Globin with Fusion Gene NUP98-HOXA10HD Expands Hematopoietic Stem Cells and Ameliorates Murine β-Thalassemia.
    Zhao HF; Abraham A; Kim YS; Wang YD; Pestina T; Zhan J; Humphries K; Nienhuis AW; Persons DA
    Mol Ther; 2017 Mar; 25(3):593-605. PubMed ID: 28190779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.
    Rivella S; May C; Chadburn A; Rivière I; Sadelain M
    Blood; 2003 Apr; 101(8):2932-9. PubMed ID: 12480689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell gene therapy for the beta-chain hemoglobinopathies. Problems and progress.
    Emery DW; Stamatoyannopoulos G
    Ann N Y Acad Sci; 1999 Apr; 872():94-107; discussion 107-8. PubMed ID: 10372114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Era for Hemoglobinopathies: More Than One Curative Option.
    Psatha N; Papayanni PG; Yannaki E
    Curr Gene Ther; 2017; 17(5):364-378. PubMed ID: 29357790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of lentiviral gene transfer approaches designed to promote fetal hemoglobin production for the treatment of β-hemoglobinopathies.
    Daniel-Moreno A; Lamsfus-Calle A; Wilber A; Chambers CB; Johnston I; Antony JS; Epting T; Handgretinger R; Mezger M
    Blood Cells Mol Dis; 2020 Sep; 84():102456. PubMed ID: 32498026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic therapy for beta-thalassemia: from the bench to the bedside.
    Arumugam P; Malik P
    Hematology Am Soc Hematol Educ Program; 2010; 2010():445-50. PubMed ID: 21239833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E
    Heffner GC; Bonner M; Christiansen L; Pierciey FJ; Campbell D; Smurnyy Y; Zhang W; Hamel A; Shaw S; Lewis G; Goss KA; Garijo O; Torbett BE; Horton H; Finer MH; Gregory PD; Veres G
    Mol Ther; 2018 Jan; 26(1):320-328. PubMed ID: 29102562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beta-globin locus control region versus gene therapy vectors: a struggle for expression.
    Ellis J; Pannell D
    Clin Genet; 2001 Jan; 59(1):17-24. PubMed ID: 11168020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for human hemoglobinopathies.
    Walsh CE; Liu JM; Miller JL; Nienhuis AW; Samulski RJ
    Proc Soc Exp Biol Med; 1993 Dec; 204(3):289-300. PubMed ID: 8234372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.